However, it is highly difficult to specifically target CD146 in cancer in general, and in TNBC in particular, essentially because of the high expression of the molecule on surrounding cells, such as the whole vascular system, and of its important physiological functions [2]. The gene discussed is MCAM; the disease is cancer.